Evidence map›Paper›PMID 32025709›Full record

ArticleThe Journal of antimicrobial chemotherapy2020

Evaluation of a fully automated bioinformatics tool to predict antibiotic resistance from MRSA genomes.

Narender Kumar, Kathy E Raven, Beth Blane, Danielle Leek, Nicholas M Brown, Eugene Bragin, Paul A Rhodes, Julian Parkhill, Sharon J Peacock

Open access · hybridAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cross-border spread ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Narender KumarDepartment of Medicine, University of Cambridge, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
Kathy E RavenDepartment of Medicine, University of Cambridge, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
Beth BlaneDepartment of Medicine, University of Cambridge, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
Danielle LeekDepartment of Medicine, University of Cambridge, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
Nicholas M BrownClinical Microbiology and Public Health Laboratory, Public Health England, Cambridge CB2 0QQ, UK.
Eugene BraginNext Gen Diagnostics, LLC (NGD), Mountain View, CA, USA and Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Paul A RhodesNext Gen Diagnostics, LLC (NGD), Mountain View, CA, USA and Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Julian ParkhillDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.
Sharon J PeacockDepartment of Medicine, University of Cambridge, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
University of Cambridge · GBPublic Health England · GB

Funding

Department of Health HICF-T5-342Wellcome TrustWellcome Trust 098051Wellcome Trust WT098600
6 · The paper itself

Abstract

objectivesThe genetic prediction of phenotypic antibiotic resistance based on analysis of WGS data is becoming increasingly feasible, but a major barrier to its introduction into routine use is the lack of fully automated interpretation tools. Here, we report the findings of a large evaluation of the Next Gen Diagnostics (NGD) automated bioinformatics analysis tool to predict the phenotypic resistance of MRSA.

methodsMRSA-positive patients were identified in a clinical microbiology laboratory in England between January and November 2018. One MRSA isolate per patient together with all blood culture isolates (total n = 778) were sequenced on the Illumina MiniSeq instrument in batches of 21 clinical MRSA isolates and three controls.

resultsThe NGD system activated post-sequencing and processed the sequences to determine susceptible/resistant predictions for 11 antibiotics, taking around 11 minutes to analyse 24 isolates sequenced on a single sequencing run. NGD results were compared with phenotypic susceptibility testing performed by the clinical laboratory using the disc diffusion method and EUCAST breakpoints. Following retesting of discrepant results, concordance between phenotypic results and NGD genetic predictions was 99.69%. Further investigation of 22 isolate genomes associated with persistent discrepancies revealed a range of reasons in 12 cases, but no cause could be found for the remainder. Genetic predictions generated by the NGD tool were compared with predictions generated by an independent research-based informatics approach, which demonstrated an overall concordance between the two methods of 99.97%.

conclusionsWe conclude that the NGD system provides rapid and accurate prediction of the antibiotic susceptibility of MRSA.

Indexed as

Methicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsComputational BiologyDrug Resistance, MicrobialEnglandGenome, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial Agents

Identifiers

PMID32025709
PMCPMC7177496
OpenAlexW2999959864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.